Study of the Combination of Acalabrutinib (ACP-196) and Pembrolizumab in Advanced Head and Neck Squamous Cell Carcinoma
Clinical trial NCT02454179 · COMPLETED
Trial details
- NCT number
- NCT02454179
- Sponsor
- Acerta Pharma BV
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-01
- Primary completion
- 2018-05-01
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.